Menu
Oncology
Granisetrona
Product Package Image
Image for illustrative purposes only.
Indication
O cloridrato de granisetrona é indicado para a prevenção e tratamento das náuseas e vômitos induzidos por terapia citostática (terapia contra o câncer) e para a prevenção e tratamento das náuseas e vômitos pós-operatório.
Active Ingredient
cloridrato de granisetrona
Concentration
1 mg/mL
Presentation
Solução injetável com 1 mg/mL. Embalagem contendo 10 ampolas com 3 mL.
Practical information
Injectable Solution
Sale under medical prescription
Oncology
Contraindication
Você não deve usar cloridrato de granisetrona se for alérgico à granisetrona ou a qualquer um dos componentes deste medicamento. Este medicamento não deve ser utilizado por mulheres grávidas sem orientação médica ou do cirurgião-dentista.
Conscious Use of Medications Manual
So that you can take better care of yourself and those you love, following a safe and effective treatment, we present the manual on the conscious use of medicines. The publication brings together a series of extremely relevant information, presented in a simple and educational way. Access the manual here
Published in: September 23, 2016  
and updated in: May 12, 2025
Se persistirem os sintomas, o médico deverá ser consultado.
Registration 1.0043.0912
Eurofarma
About The Company Areas of Expertise Join Our Staff Media Eurofarma Certifications Warnings Awards and Recognition Visitation Program Where We Operate Newsroom
Products
Generic Drugs Hospital Nonprescription Drugs Oncology Prescription Drugs
Innovation
Biotechnology Eurolab New Business Conduct Clinical Research With Us Research and Development
Sustainability
Sustainability Booklet Corporate Governance Environment Sustainability Report Corporate Responsibility Sustainability Vision Balance Sheet
© Eurofarma 2025
Privacy Policy